Clinical PhasesI think that many investors feel that at this stage TLT is far too early to see what lies ahead. I have a link below that what shows as great promise in Phase 2 is often not seen in Phase 3. And we are just entering Phase 2 and Phase 2 may not show the efficacy that the few patients in Phase 1 showed.
I remain invested in TLT and will wait and see what happens. If it is positive, I should see a very nice gain. And if results are negative, I will sell and take a loss.
Phase 2 vs Phase 3